Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

248
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
248
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

193
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
193
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

3.7K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fractional Exhaled Nitric Oxide (FeNO) as a Biomarker of Lower Airway Eosinophilic Inflammation: Benefits and Limitations.

Journal of inflammation research·2026
Same author

Real-World Effectiveness and Safety of Extrafine Triple Therapy in COPD Patients with Comorbid and Cardiovascular Conditions.

International journal of chronic obstructive pulmonary disease·2026
Same author

Remission in Global Airway Diseases: EUFOREA Consensus Paper.

Allergy·2026
Same author

Prevalence and impact of psychiatric and neurocognitive comorbidities on pulmonary rehabilitation outcomes.

European journal of internal medicine·2026
Same author

Access to pulmonary rehabilitation in real-world territorial care: the APTA friendly network as a structural and organizational model.

BMC health services research·2026
Same author

Skeletal muscle dysfunction in COPD: miRNAs, myokines and exercise.

ERJ open research·2026

Related Experiment Video

Updated: Jun 19, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.6K

A clinician's guide to single vs multiple inhaler therapy for COPD.

Mario Cazzola1, Josuel Ora2, Mauro Maniscalco3,4

  • 1Department of Experimental Medicine, University of Rome "Tor Vergata", Rome, Italy.

Expert Review of Respiratory Medicine
|July 24, 2024
PubMed
Summary

Choosing between single and multiple inhaler therapies for chronic obstructive pulmonary disease (COPD) requires careful patient evaluation. Personalized approaches optimize COPD management and patient well-being, with ongoing research needed for definitive strategies.

Keywords:
Chronic obstructive pulmonary diseasecost-effectivenessinhaler therapymultiple inhalerspatient adherenceshared decision-makingsingle inhalertreatment customizationtreatment goals

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.5K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.3K

Related Experiment Videos

Last Updated: Jun 19, 2025

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

40.6K
Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

13.5K
Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.3K

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Patient Care

Background:

  • Inhalation therapy is crucial for managing chronic obstructive pulmonary disease (COPD).
  • Clinicians face a critical decision between single and multiple inhaler therapies.
  • This choice impacts treatment efficacy, patient adherence, and disease management outcomes.

Purpose of the Study:

  • To examine the advantages of single versus multiple inhaler therapies for COPD.
  • To identify key factors influencing the selection of inhaler therapy regimens.
  • To discuss personalized treatment approaches and shared decision-making in COPD management.

Main Methods:

  • Review of current clinical practices and literature on COPD inhalation therapies.
  • Analysis of the benefits and drawbacks of single and multiple inhaler systems.
  • Consideration of patient-specific needs, preferences, and adherence factors.

Main Results:

  • Single inhaler therapy offers simplicity and convenience.
  • Multiple inhaler therapy allows for greater flexibility and customization.
  • Personalized treatment selection is essential for optimizing COPD management.

Conclusions:

  • Clinicians must tailor inhaler therapy to individual patient needs for optimal COPD management.
  • Further unbiased clinical trials are needed to compare single versus multiple inhaler strategies.
  • Smart inhaler technology shows promise for enhancing adherence and personalized care, but its comparative effectiveness in different regimens requires further investigation.